Efficacy of 448kilohertz Capacitive Resistive Monopolar Radiofrequency Stimulation in Chronic Shoulder Pain
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
448kilohertz capacitive resistive monopolar radiofrequency is a novel technique in physiotherapy and its usefulness and clinical relevance is still to be investigated. Current studies show promising results in different musculoskeletal disorders, however further studies with proper designs and conclusive findings are necessary.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2020
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 15, 2019
CompletedFirst Posted
Study publicly available on registry
January 29, 2020
CompletedStudy Start
First participant enrolled
March 30, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedJanuary 29, 2020
January 1, 2020
2 months
October 15, 2019
January 26, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Change from Baseline ultrasound imaging at 3 months
Elastography
time (t) 1(prior to treatment), t2 (immediately after the treatment), t3 (3 months later)
Change from Baseline ultrasound imaging at 3 months
Tendon thickness
time (t) 1(prior to treatment), t2 (immediately after the treatment), t3 (3 months later)
Secondary Outcomes (8)
Electromyography
time (t) 1(prior to treatment), t2 (immediately after the treatment), t3 (3 months later)
Change from Baseline dynamometry at 3 months
time (t) 1(prior to treatment), t2 (immediately after the treatment), t3 (3 months later)
Algometry
time (t) 1(prior to treatment), t2 (immediately after the treatment), t3 (3 months later)
Range of movement
time (t) 1(prior to treatment), t2 (immediately after the treatment), t3 (3 months later)
Change from baseline SPADI (Shoulder Pain And Disability Index) questionnaire at three months
time (t) 1(prior to treatment), t2 (immediately after the treatment), t3 (3 months later)
- +3 more secondary outcomes
Study Arms (3)
INTERVENTION
EXPERIMENTAL448 kilohertz Capacitive Resistive Monopolar Radiofrequency stimulus on the shoulder
Placebo Monopolar Radiofrequency stimulus
EXPERIMENTALTo simulate the application of Monopolar Radiofrequency stimulus on the affected shoulder
No intervention group
EXPERIMENTALTo evaluate at the same time than the others groups but without being treated with 448 kilohertz Capacitive Resistive Monopolar Radiofrequency.
Interventions
448kilohertz capacitive resistive monopolar radiofrequency will be applied on the shoulder and thoracic area
A simulation of 448kilohertz capacitive resistive monopolar radiofrequency will be carried out to make believe the patient to be treated through this equipment.
These participants will be assessed at the same time than the rest of participants. They will not receive any kind of treatment.
Eligibility Criteria
You may qualify if:
- To suffer from shoulder pain more than three months.
- Men or women aged between 18 to 65 years;
- Unilateral pain located in the anterior and/or lateral shoulder region;
- out of 3 positive clinical tests (Hawkins-Kennedy; Jobe; Neer);
- Pain with normal activity ≥ 4/10 on a visual analogue scale;
- Nontraumatic onset of shoulder pain.
You may not qualify if:
- History of significant shoulder trauma, such as fracture or ultrasonography-clinically suspected full thickness cuff tear, following the classification of Wiener and Seitz
- Recent shoulder dislocation in the past two years
- Systemic illnesses such as rheumatoid arthritis
- Adhesive capsulitis of the shoulder
- Shoulder pain originating from the neck or if there was a neurological impairment, osteoporosis, hemophilia and/or malignancies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- UNIVERSITY PROFESSOR
Study Record Dates
First Submitted
October 15, 2019
First Posted
January 29, 2020
Study Start
March 30, 2020
Primary Completion
May 30, 2020
Study Completion
December 31, 2020
Last Updated
January 29, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share